Results 41 to 50 of about 43,328 (269)

Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target

open access: yesCell Communication and Signaling, 2019
Background Chondrosarcoma is a malignant cartilaginous neoplasm of the bone which resistant to radiation therapy and chemotherapy. Cyclin-dependent kinase 4 (CKD4) is highly expressed in human cancer, and palbociclib, the inhibitor of CDK4 has been used ...
Zhengxiao Ouyang   +6 more
doaj   +1 more source

Extra-articular synovial chondromatosis of the ankle: Unusual case with radiologic-pathologic correlation. [PDF]

open access: yes, 2020
Extra-articular synovial chondromatosis is a rare entity in the foot and ankle. We present a case of a 49-year-old female who presented for evaluation of a palpable concern following trauma; which was found to represent synovial chondromatosis. This case
Abraham, John   +6 more
core   +1 more source

Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution. [PDF]

open access: yes, 2019
Background:Dedifferentiated chondrosarcomas (DDCSs) are highly malignant tumors with a dismal prognosis and present a significant challenge in clinical management.
Chebib, Ivan   +10 more
core   +1 more source

Mucoepidermoid carcinoma associated with osteosarcoma in a true malignant mixed tumor of the submandibular region [PDF]

open access: yes, 2015
True malignant mixed tumor, also known as carcinosarcoma, is a rare tumor of the salivary gland composed of both malignant epithelial and malignant mesenchymal elements.
Cerbelli, B   +4 more
core   +3 more sources

Lymph node metastasis in extremity chondrosarcomas

open access: yesSouth Asian Journal of Cancer, 2020
Bacground: Primary bone sarcomas mainly metastasize through haematogenous route and rarely through lymph nodes due to paucity of lymphatic channels in the bone (1).
Vineet Kurisunkal   +3 more
doaj   +1 more source

Advanced chondrosarcoma of the pelvis: a rare case of urinary obstruction [PDF]

open access: yes, 2019
Chondrosarcoma is the second most common malignant tumor of the bone with an incidence of 1 in 200.000 per year. Axial skeleton is frequently involved showing poorer oncological outcomes than appendicular one: human pelvis is a site predilection.
Annoscia, Scipio   +8 more
core   +1 more source

The potential for dietary factors to prevent or treat osteoarthritis [PDF]

open access: yes, 2014
Osteoarthritis (OA) is a degenerative joint disease for which there are no disease-modifying drugs. It is a leading cause of disability in the UK. Increasing age and obesity are both major risk factors for OA and the health and economic burden of this ...
Bao, Yongping   +8 more
core   +1 more source

Mesenchymal Chondrosarcoma [PDF]

open access: yesInternational Journal of Particle Therapy, 2016
To review the treatment and outcomes of patients with mesenchymal chondrosarcomas (MC).Review of the pertinent literature.MC is a rare aggressive small round blue cell malignancy that may arise in either bone or soft tissue. It usually presents in the 2nd or 3rd decade of life and exhibits an approximately equal gender predilection.
William M, Mendenhall   +4 more
openaire   +2 more sources

Multi-modality management of chondrosarcoma of scapula: A case report and review of literature

open access: yesCancer Treatment and Research Communications, 2023
Chondrosarcoma are malignant tumours in which neoplastic cells produce cartilage. The most commonly affected sites are pelvis, femur, humerus and ribs. Scapula involvement is relatively rare.
Ramakant Tiwari   +5 more
doaj   +1 more source

The in ovo CAM-assay as a xenograft model for sarcoma [PDF]

open access: yes, 2013
Sarcoma is a very rare disease that is heterogeneous in nature, all hampering the development of new therapies. Sarcoma patients are ideal candidates for personalized medicine after stratification, explaining the current interest in developing a ...
Bracke, Marc   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy